Skip to main content

and
  1. Article

    Open Access

    Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults

    Osteoporosis and Alzheimer’s disease (AD) mainly affect older individuals, and the possibility of an underlying link contributing to their shared epidemiological features has rarely been investigated. In the c...

    Jun Yuan, Steve Pedrini, Rohith Thota, James Doecke, Pratishtha Chatterjee in npj Aging (2023)

  2. Article

    Open Access

    Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

    Glial fibrillary acidic protein (GFAP), an astrocytic cytoskeletal protein, can be measured in blood samples, and has been associated with Alzheimer’s disease (AD). However, plasma GFAP has not been investigat...

    Pratishtha Chatterjee, Steve Pedrini, Erik Stoops in Translational Psychiatry (2021)

  3. Article

    Open Access

    Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer’s disease pathology

    Heme and iron homeostasis is perturbed in Alzheimer’s disease (AD); therefore, the aim of the study was to examine the levels and association of heme with iron-binding plasma proteins in cognitively normal (CN...

    Azhaar Ashraf, Nicholas J. Ashton, Pratishtha Chatterjee in Alzheimer's Research & Therapy (2020)

  4. No Access

    Article

    Personality factors and cerebral glucose metabolism in community-dwelling older adults

    Personality factors have been associated with Alzheimer’s disease (AD) and dementia, but they have not been examined against markers of regional brain glucose metabolism (a primary measure of brain functioning...

    Hamid R. Sohrabi, Kathryn Goozee, Michael Weinborn in Brain Structure and Function (2020)

  5. Article

    Open Access

    Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

    Blood markers indicative of neurodegeneration (neurofilament light chain; NFL), Alzheimer’s disease amyloid pathology (amyloid-β; Aβ), and neuroinflammation (kynurenine pathway; KP metabolites) have been inves...

    Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee in Journal of Neuroinflammation (2019)

  6. Article

    Open Access

    Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study

    The kynurenine pathway (KP) is dysregulated in neuroinflammatory diseases including Alzheimer’s disease (AD), however has not been investigated in preclinical AD characterized by high neocortical amyloid-β loa...

    Pratishtha Chatterjee, Kathryn Goozee, Chai K. Lim, Ian James in Scientific Reports (2018)

  7. Article

    Open Access

    Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease

    Brain and blood fatty acids (FA) are altered in Alzheimer’s disease and cognitively impaired individuals, however, FA alterations in the preclinical phase, prior to cognitive impairment have not been investiga...

    Kathryn Goozee, Pratishtha Chatterjee, Ian James, Kaikai Shen in Scientific Reports (2017)

  8. Article

    Open Access

    Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease

    Retinal imaging may serve as an alternative approach to monitor brain pathology in Alzheimer’s disease (AD). In this study, we investigated the association between retinal vascular and structural changes and c...

    S.Mojtaba Golzan, Kathryn Goozee, Dana Georgevsky in Alzheimer's Research & Therapy (2017)